Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
| Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Neuroendocrine tumors medical therapy|Medical Therapy]] | [[Neuroendocrine tumors surgery|Surgery]] | [[Neuroendocrine tumors | [[Neuroendocrine tumors medical therapy|Medical Therapy]] | [[Neuroendocrine tumors surgery|Surgery]] | [[Neuroendocrine tumors primary prevention|Primary Prevention]] | [[Neuroendocrine tumors cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neuroendocrine tumors future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Neuroendocrine tumors case study one|Case #1]] | [[Neuroendocrine tumors case study one|Case #1]] | ||
Revision as of 03:42, 11 September 2012
| Neuroendocrine tumors | |
| ICD-9 | 209 |
|---|---|
| ICD-O: | M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 |
| MeSH | D018358 |
|
Neuroendocrine tumors Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Neuroendocrine tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | PET | Endoscopy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.